Published: Apr, 2018

According to a new market report published by Transparency Market Research titled ‘Smoking Cessation and Nicotine De-Addiction Market [(Products (with Nicotine) -  (OTC Products and Prescription Products); (OTC Products - E-cigarettes, Nicotine Gums (NRT), Nicotine Patches (NRT), Nicotine Lozenges (NRT) and Nicotine Tablets (NRT)); (Prescription Products - Nicotine Sprays (NRT) and Nicotine Inhalers (NRT))]; [Products (without Nicotine) – (Prescription Products -  Zyban and  Chantix)] – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 – 2026, the global smoking cessation and nicotine de-addiction market is expected to reach US$ 13,657.6 Mn by 2026, expanding at a CAGR of 4.5% from 2018 to 2026. The market is segmented by regions into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South America. 

The North America smoking cessation and nicotine de-addiction market is the largest in the world. In North America, nicotine containing smoking cessation products hold a major market share. In North America, OTC smoking cessation and nicotine de-addiction products hold a significant share of the market compared to nicotine containing prescription smoking cessation products. E-cigarette is the most dominant type of nicotine containing OTC smoking cessation product in North America. The U.S. is the largest smoking cessation and nicotine de-addiction market in North America and the world. Canada is the second largest smoking cessation market in North America. The smoking cessation and nicotine de-addiction market in Europe is the second largest in the world. 

global smoking cessation nicotine market

Request A Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1849

In the Europe smoking cessation and nicotine de-addiction market, nicotine containing OTC products hold a prominent share compared to nicotine containing prescription products. Nicotine containing OTC products such as e-cigarettes, nicotine gum, nicotine transdermal patches, nicotine lozenges, and nicotine tablets are most popular among European consumers. The number of e-cigarette consumers is increasing in major European countries. EU e-cigarette regulations apply to EU countries and are not applicable in the U.K. after Brexit. The U.K. is the second largest smoking cessation and nicotine de-addiction market in the world after the U.S. and the largest market in Europe. France and Germany are the second and third largest smoking cessation markets in Europe. 

The Asia Pacific smoking cessation and nicotine de-addiction market is the third largest market in the world. In the Asia Pacific smoking cessation and nicotine de-addiction market, nicotine containing OTC products hold a dominant share compared to nicotine containing prescription products. Nicotine containing OTC products such as e-cigarettes, nicotine gum, nicotine transdermal patches, nicotine lozenges, and nicotine tablets are increasing their penetration in the Asia Pacific region. China is the largest smoking cessation and nicotine de-addiction market in Asia Pacific. Japan and India are the second and third largest smoking cessation markets in the region. 

In MEA, it is estimated that 180 million men are expected to be smokers by 2025 which is 2X the number of smokers in the region in the year 2000. In 2002, the tobacco market in MEA was worth US$ 15.3 billion which increased to US$ 28.7 billion in 2009 and is expected to reach US$ 50.0 billion in 2020. As tobacco consumption is increasing in MEA, ill effects of tobacco are bound to increase, which is expected to drive the demand for smoking cessation and nicotine de-addiction products in the region. 

The South America smoking cessation and nicotine de-addiction market is the smallest in the world. Brazil is the largest smoking cessation and nicotine de-addiction market in South America. 

The study provides a conclusive view of the global smoking cessation and nicotine de-addiction market by segmenting it in terms of product type and distribution channel. In terms of product type, the global smoking cessation and nicotine de-addiction market has been classified into products (with nicotine) and products (without nicotine). Products (with nicotine) are further sub-segmented into OTC products and prescription products. OTC products are categorized into e-cigarettes, nicotine gums (NRT), nicotine patches (NRT), nicotine lozenges (NRT), and nicotine tablets (NRT). Similarly, prescription products are divided into nicotine sprays (NRT) and nicotine inhalers (NRT). Products (without nicotine) are prescription products and are segmented into Zyban and Chantix. By distribution channel, the global smoking cessation and nicotine de-addiction market is segmented into online and offline. NRT stands for products that help to reduce the urge for smoking i.e. nicotine replacement therapy (NRT).         

The report highlights major companies operating in the global smoking cessation and nicotine de-addiction market including Pfizer Inc., GlaxoSmithKline plc (GSK), Cipla Ltd., Johnson & Johnson (J&J), ITC Ltd., Takeda Pharmaceutical Company Ltd., Alkalon A/S, 22nd Century Group, Inc., Strides Pharma Science Ltd., and JUUL Labs, Inc.   

The global smoking cessation and nicotine de-addiction market is segmented as below:

Global Smoking Cessation and Nicotine De-Addiction Market, by Product Type

  • Products (with Nicotine)
    • OTC Products
      • E-cigarettes
      • Nicotine Gums (NRT)
      • Nicotine Patches (NRT)
      • Nicotine Lozenges (NRT)
      • Nicotine Tablets (NRT)
    • Prescription Products
      • Nicotine Sprays (NRT)
      • Nicotine Inhalers (NRT)
    • Products (without Nicotine)
      • Prescription Products
        • Zyban
        • Chantix 

Global Smoking Cessation and Nicotine De-Addiction Market, by Distribution Channel

  • Online
  • Offline 

Global Smoking Cessation and Nicotine De-Addiction Market, by Geography

  • North America
    • U.S.
    • Canada
    • Rest of North America  
  • Europe
    • U.K.
    • France
    • Germany
    • Rest of Europe 
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific  
  • Middle East & Africa (MEA)
    • GCC
    • South Africa
    • Rest of MEA 
  • South America
    • Brazil
    • Rest of South America 

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

.